Michael Howard Morse

Michael Howard Morse

Cooley LLP • Washington, DC
Antitrust Trade LawReal Estate

Is this your profile?

Claim it for free to update your information and connect with clients.

Claim Profile →

Contact

Email
Phone
(866) 970-5268
Address
777 6th Street, Washington, DC, 20001-3723, US

Professional

About

Michael Howard Morse is a distinguished attorney based in Washington, DC, with a robust practice at Cooley LLP. With extensive experience in Antitrust & Trade Law, Intellectual Property, and Mergers & Acquisitions, Michael is recognized for his strategic acumen and exceptional advocacy skills. His commitment to his clients has earned him accolades in the Chambers USA Guide to America’s Leading Lawyers, which highlights him as "a tireless advocate" known for his "superb analytical and communications skills." Before joining Cooley LLP, Michael served as the Assistant Director of the Federal Trade Commission's Bureau of Competition, where he gained invaluable insights into regulatory practices and enforcement. This background informs his approach to complex legal challenges, allowing him to navigate intricate antitrust issues and effectively represent his clients' interests in high-stakes negotiations and litigation. Michael’s clients benefit from his practical experience and deep understanding of the legal landscape, which he leverages to develop innovative solutions tailored to their specific needs. His dedication to excellence and client service has made him a respected figure in his field, as he consistently strives to achieve optimal outcomes for those he represents. In an ever-evolving legal environment, Michael Howard Morse stands out as a trusted advisor, committed to guiding clients through the intricacies of Antitrust and Intellectual Property law while facilitating successful Mergers & Acquisitions.

About Antitrust Trade Law

Antitrust attorneys handle matters involving competition law, market practices, and trade regulations. They help businesses comply with antitrust laws and defend against claims. Common matters include price fixing, monopoly claims, merger review, trade practices.

Credentials

Education
1984 Harvard Law School J.D., cum laude 1981 Dartmouth College A.B., summa cum laude
Languages
English

Recognition & Involvement

Awards
2011 America’s Leading Lawyers for Business, Chambers USA: 2008 Guide to the World’s Leading Lawyers, Legal Media Group 2007 SuperLawyer, Washington, D.C. Super Lawyers 1997 Award for Superior Service, Federal Trade Commission Commission
Publications
2011 CooleyAlerts! Hart-Scott-Rodino Thresholds Revised 2010 CooleyAlerts! U.S. Antitrust Authorities Issue New Merger Guidelines 2010 Cooley Alerts! Analyst Calls: Another Reason to Exercise Caution — FTC Challenges CEO's Statements as an "Invitation to Collude" 2009 Antitrust Update FTC and State of California Challenge Pharmaceutical Patent Litigation Settlements in Federal Court 2009 Antitrust Update Hart-Scott-Rodino Act Developments: New Filing Thresholds, New Penalties and New Enforcement Activities
Associations
2009 - Present American Bar Association, Section of Antitrust Law, Federal Civil Enforcement Committee Chair 2004 - 2007 Intellectual Property Owners Association, Antitrust & Competition Law Committee Vice-Chair 1997 - 2009 American Bar Association, Section of Antitrust Law, Computer, Intellectual Property and Exemptions & Immunities Committees Chair
Speaking
2011 Antitrust Counseling & Compliance 2011 The Merger Review Process 2010 ABA Litigation Section Enforcement Priorities of the Obama Administration: What is Happening at the DOJ and FTC 2009 48th Annual Advanced Antitrust Seminar “Intellectual Property Licensing and Recent Developments in Standard Setting” 2008 The Fourth Annual Conference on Current Issues in Complex IP Licensing New Developments at the Intersection of Antitrust Law and Intellectual Property Protection 2008 4th Annual In-House Counsel Forum on Pharmaceutical Antitrust Assessing What the Authorized Generic Drug Study and Report on Intellectual Property Collectively Mean for the Pharmaceutical Industry
Updated: Mar 25, 2026